Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease.

Literature DB >> 10413727

Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease.

M Cazzola¹, C F Donner, M G Matera.

Abstract

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 1999 PMID： 10413727 PMCID： PMC1745553 DOI： 10.1136/thx.54.8.730

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

× No keyword cloud information.

72 in total

1. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey.

Authors: C Janson; S Chinn; D Jarvis; P Burney
Journal: Eur Respir J Date: 1997-08 Impact factor: 16.671

Review 2. Management of COPD. Early identification and active intervention are crucial.

Authors: G T Ferguson
Journal: Postgrad Med Date: 1998-04 Impact factor: 3.840

3. Organized care in general practice: structure and evaluation.

Authors: M L Levy
Journal: Respir Med Date: 1997-11 Impact factor: 3.415

Review 4. The use of bronchodilators in stable chronic obstructive pulmonary disease.

Authors: M Cazzola; D Spina; M G Matera
Journal: Pulm Pharmacol Ther Date: 1997-06 Impact factor: 3.410

5. Salmeterol versus theophylline in the treatment of asthma.

Authors: S J Pollard; S L Spector; S W Yancey; F M Cox; A Emmett
Journal: Ann Allergy Asthma Immunol Date: 1997-05 Impact factor: 6.347

6. Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients of salmeterol.

Authors: S F Lanes; L L Lanza; C E Wentworth
Journal: Am J Respir Crit Care Med Date: 1998-09 Impact factor: 21.405

Review 7. Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease.

Authors: A Ikeda; K Nishimura; T Izumi
Journal: Drugs Aging Date: 1998-02 Impact factor: 3.923

8. Effects of theophylline on respiratory drive in patients with chronic obstructive pulmonary disease.

Authors: K Ashutosh; M Sedat; J Fragale-Jackson
Journal: J Clin Pharmacol Date: 1997-12 Impact factor: 3.126

Review 9. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?

Authors: B J Lipworth
Journal: Drug Saf Date: 1997-05 Impact factor: 5.228

10. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.

Authors: M Tsukino; K Nishimura; A Ikeda; T Hajiro; H Koyama; T Izumi
Journal: Thorax Date: 1998-04 Impact factor: 9.139

7 in total

Review 1. β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.

Authors: Maria Gabriella Matera; Luigino Calzetta; Mario Cazzola
Journal: Drugs Date: 2013-10 Impact factor: 9.546

Review 2. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.

Authors: B Jarvis; A Markham
Journal: Drugs Aging Date: 2001 Impact factor: 3.923

3. Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.

Authors: M Cazzola; F Di Perna; S Centanni; C Califano; C F Donner; M D'Amato; G D'Amato
Journal: Thorax Date: 1999-12 Impact factor: 9.139